286
Views
16
CrossRef citations to date
0
Altmetric
Review

Erectile dysfunction and cardiovascular disease

, &

References

  • Tsertsvadze A, Yazdi F, Fink HA, et al. Diagnosis and treatment of erectile dysfunction. Evidence Reports/Technology Assessments, 171 Rockville, MD; Agency for Healthcare Research and Quality (US): 2009.
  • DeBusk R, Drory Y, Goldstein I, et al. Management of sexual dysfunction in patients with cardiovascular disease. Am J Cardiol 2000;86:175–81.
  • Levine LA. Erectile dysfunction: causes, diagnosis and treatment. Compr Ther 1989;15:54–8.
  • Centers for Disease Control and Prevention. Leading causes of death in the United States, final 2009 data. FastStats; Available from: http://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm.
  • Haczynski J, Lew-Starowicz Z, Darewicz B, et al. The prevalence of erectile dysfunction in men visiting outpatient clinics. Int J Impot Res 2006;18:359–63.
  • National Institutes of Health. Consensus development panel on impotence. JAMA 1993;270:83–90.
  • Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the massachusetts male aging study. J Urol 1994;151:54–61.
  • Miner M, Seftel AD, Nehra A, et al. Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. Am Heart J 2012;164:21–8.
  • Billups KL, Bank AJ, Padma-Nathan H, et al. Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res 2008;20:236–42.
  • Kloner RA. Erectile dysfunction as a predictor of cardiovascular disease. Int J Impot Res 2008;20:460–5.
  • Thompson I, Tangen CM, Goodman PJ, et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005;294:2996–3002.
  • Banks E, Joshy G, Abhayaratna WP, et al. Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study. PLoS Med 2013;10:e1001372.
  • Odriozola AA, Quintanilla MG, Arias JG, et al. Vascular erectile dysfunction. Arch Esp Urol 2010;63:611–20.
  • Raines EW, Ros E. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 1993;69(Suppl):S30–7.
  • Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986;314:488–500.
  • Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms. Circulation 1995;91:2488–96.
  • Cooley DA. In memoriam: tribute to rene favaloro, pioneer of coronary bypass. Tex Heart Inst J 2000;27:231–2.
  • Favaloro RG, Effler DB, Groves LK, et al. Direct myocardial revascularization with saphenous vein autograft: clinical experience in 100 cases. Chest 1969;56:279–83.
  • Babaev A, Jhaveri RR. Angiography and endovascular revascularization of pudendal artery atherosclerotic disease in patients with medically refractory erectile dysfunction. J Invasive Cardiol 2012;24:236–40.
  • Dewey M, Hoffmann H, Hamm B. Multislice CT coronary angiography: effect of sublingual nitroglycerine on the diameter of coronary arteries [article in German]. Progr Roentgenol 2006;178:600–4.
  • Keats TE, Sistrom C. Atlas of radiologic measurement. 7th ed. Philadelphia, PA: Mosby; 2001. p 609.
  • Bookstain JJ, Lang EV. Penile magnification pharmacoarteriography: details of intrapenile arterial anatomy. Am J Roentgenol 1987;148:883–8.
  • Azadzoi KM, Park K, Andry C, Goldstein I, Siroky MB. Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model. J Urol 1997;157:1011–17.
  • Bae JH. Noninvasive evaluation of endothelial function. J Cardiol 2001;37:89–92.
  • Jackson G. Erectile dysfunction and coronary disease: evaluating the link. Maturitas 2012;72:263–4.
  • Montorsi P, Ravagnani M, Galli S, et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol 2005;96(Suppl):19M–23M.
  • Schwartz BG, Kloner RA. Clinical cardiology: physician update: erectile dysfunction and cardiovascular disease. Circulation 2001;123:98–101.
  • Rosen RC. Psychogenic erectile dysfunction: classification and management. Urol Clin North Am 2001;28:269–78.
  • Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319–26.http://www.hiv.va.gov/provider/manual-primary-care/urology-tool2.asp.
  • Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536–59.
  • Meldrum DR, Gambone JC, Morris MA, et al. The link between erectile and cardiovascular health: the canary in the coal mine. Am J Cardiol 2011;108:599–606.
  • Wrishko R, Sorsaburu S, Wong D, et al. Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil. J Sex Med 2009;6:2039–48.
  • Andersson KE. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev 2001;63:811–59.
  • Randrup ER, Wilson S, Mobley D, Suarez G, Mekras G, Baum N. Clinical experience with mentor Alpha I inflatable prosthesis: report on 333 cases. Urology 1993;42:305–8.
  • Randrup E. Clinical experience with 180 inflatable penile prostheses. South Med J 1995;88:47–51.
  • Atienza Merino G. Penile prosthesis for the treatment of erectile dysfunction. Actas Urol Esp 2006;30:159–69.
  • Morales A, Condra M, Owen JA, et al. Is yohimbine effective in the treatment of organic impotence? results of a controlled trial. J Urol 1987;137:1168–72.
  • Mann K, Klingler T, Noe S, et al. Effects of yohimbine in sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Arch Sex Behavior 1996;25:1–16.
  • Nehra A, Jackson G, Miner M, et al. The princeton III consensus recommendations for the management of erectile dysfunction. Mayo Clin Proc 2012;87:766.
  • Hodges D, Kirby M, Solanki J, et al. The temporal relationship between erectile dysfunction and cardiovascular disease. Int J Clin Pract 2007;61:2119–025.
  • English KM, Steeds RP, Jones TH, et al. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 2000;102:1906–11.
  • Malkin CJ, Pugh PJ, Morris PD, et al. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and mood. Heart 2004;90:871–6.
  • Nieschlag E, Behre HM, Bouchard P, et al. Testosterone replacement therapy: current trends and future directions. Hum Reprod Update 2004;10:409–19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.